Skip to main content

Table 1 The results of the pharmacokinetic study

From: Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative

Parameter Value
Ke,1/h 0.017
t1/2, h 4.11
Cmax, µmol/L 0.087
AUC0–6 h, µmol/L × h 0.13
AUC0–∞, µmol/L × h 0.19
  1. K e elimination rate constant, t 1/2 elimination half-life, C max maximum concentration in plasma, AUC area under the plasma concentration–time curve up to 6 h and extrapolated to infinity